Analyze Publications Database

PPARδ activation normalizes cardiac substrate metabolism and reduces right ventricular hypertrophy in congestive heart failure

Jucker BM, Doe CP, Schnackenberg CG, Olzinski AR, Maniscalco K, Williams C, Hu TC, Lenhard SC, Costell M, Bernard R, Sarov-Blat L, Steplewski K, Willette RN. PPARδ activation normalizes cardiac substrate metabolism and reduces right ventricular hypertrophy in congestive heart failure. J Cardiovasc Pharmacol. July 2007;50(1):25-34.

Publication Date
July 2007

How Analyze was Used
“The imaging parameters were as follows: matrix dimensions, 128 × 128; TR/TE, 20/3.7 ms; slice thickness, 2.0 mm; FOV, 5.0 cm; 4 averages; sine loop, 10 images. Left ventricle (LV) functional parameters were analyzed (Analyze AVW software, AnalyzeDirect, Lenexa, KS).”

Keywords
Animals
Biological Transport
Diuresis/drug effects
Dose-Response Relationship, Drug
Energy Metabolism
Gene Expression/drug effects
Heart Failure/drug therapy/etiology/physiopathology
Hypertrophy, Right Ventricular/drug therapy/etiology/physiopathology
Lipids/blood
Magnetic Resonance Spectroscopy
Male
Myocardial Infarction/complications
Oxidation-Reduction
PPAR delta/agonists/metabolism
Pulmonary Edema/drug therapy/etiology
Rats
Rats, Sprague-Dawley
Reverse Transcriptase Polymerase Chain Reaction
Ventricular Function, Left/drug effects

Author Affiliation(s)
Cardiovascular and Urogenital Center of Excellence for Drug Discovery, and Genomics Research, GlaxoSmithKline, King of Prussia, PA 19406, US.

ID# 1696

Tags: , , , , , , , , , , , , , , , , , , ,